Since its approval, there have been no cases of torsades de pointes or unexplained sudden death among US patients treated with Caprelsa.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback